Key facts
- This page summarizes Jason Warnock's Form 3 filing for Flora Growth Corp. (FLGC).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2023, 15:04.
Jason Warnock - 01 Jan 2023 Form 3 Insider Report for Flora Growth Corp. (FLGC)
- Reporting owner signature
- /s/ Matthew Cohen as Attorney-in-Fact for Jason Warnock
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jason Warnock filed Form 3 for Flora Growth Corp. (FLGC) on 03 Jan 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FLGC
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 335,801
- Date
- 01 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FLGC
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 16,667
- Exercise price
- $5.20
- Footnotes
- F3
FLGC
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 75,000
- Exercise price
- $2.04
- Footnotes
- F3
FLGC
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 153,061
- Exercise price
- $0.6700
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These Common Shares contain restricted share grants to the Reporting Person by the issuer as further described in footnote (2) below.
Footnote F2
The Common Shares reported include the following Restricted Common Shares (i) 102,040 shares which vest on July 5, 2023, (ii) 93,283 shares which vest on July 5, 2024 and (iii) 132,978 shares which vest on July 5, 2025.
Footnote F3
These options are immediately exercisable.
Footnote F4
These options shall vest if (i) the total shareholder return of the Issuer's Common Shares on the Nasdaq Capital Market exceeds the total shareholder return on the ETFMG Alternative Harvest ETF for the 12 months ended December 31, 2023, which shall be measured on December 31, 2023 or (ii) the total shareholder return of the Issuer's Common Shares on the Nasdaq Capital Market exceeds the total shareholder return on the ETFMG Alternative Harvest ETF for the 12 months ended December 31, 2024, which shall be measured on December 31, 2024.